Rongtai Health Releases 2026 Interim Report with Net Profit of 112 Million Yuan

Jiemian··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Rongtai Health released its 2026 interim report, with net profit attributable to the parent company of 112 million yuan. The company's total operating revenue was 991 million yuan, and net cash flow from operating activities was negative 1.63 million yuan, down 101.81 percent from the same period last year. The latest asset-liability ratio was 28.58 percent, gross margin was 29.31 percent, ROE was 4.07 percent, and diluted earnings per share was 0.56 yuan.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews